Peer-Reviewed Publications
1. Brandt CR, Kintner RL, Pumfery AM, Visalli RJ, and Grau DR.
The herpes simplex virus ribonucleotide reductase is required for ocular
virulence. J Gen Virol 72:2043-2049, 1991.
2. Balish MJ, Abrams ME, Pumfery AM, and Brandt CR. Enhanced
inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts
by combinations of interferon α and γ. J Inf Dis 166:1401-1403, 1992.
3. Brandt CR, Pumfery AM, Micales B, Bindley CD,
Lyons GE, Sramek SJ, and Wallow IHL. Renin mRNA is synthesized locally in rat
ocular tissues. Curr Eye Res 13:755-763, 1994.
4. Pumfery AM and Brandt CR.
Thymidine kinase and susceptibility to interferon are not involved in
the increased virulence of recombinant viruses isolated following mixed ocular
infection with HSV-1 strains OD4 and CJ394.
Ophthalmic Res 28:125-129, 1996.
5. Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Azumi
N, Kishishita M, Brady JN, Doniger J, Medveczky P, and Rosenthal LJ. Identification of kaposin (open reading fram
K12) as a human herpes virus 8 (kaposi’s sarcoma-associated herpes virus)
transforming gene. J Virol
72:4980, 1998.
6. de la Fuente C, Santiago F,
Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, and Kashanchi F. Gene expression profile of HIV-1 tat
expressing cells: a close interplay between proliferative and differentiation
signals. BMC Biochem 3:14, 2002.
7. Deng L, Ammosova T, Pumfery A, Kashanchi F, and Nekhai S.
HIV-1 Tat interaction with RNA polymerase II CTD and a dynamic association with
CDK2 induces CTD phosphorylation and transcription from HIV-1 promoter. J
Biol Chem 277:33922-33929, 2002.
8. de la Fuente C, Wang L, Wang
D, Deng L, Wu K, Hong L, Stein D, Denny
T, Coffman F, Kehn K, Baylor S, Maddurkuri A, Pumfery AM, and Kashanchi
F. Paradoxical effects of a stress
signal on pro-and anti-apoptotic machinery. Mol Cell Biochem 245:99-113,
2003.
9. Brandt CR, Kolb AW, Shah DD, Pumfery
AM, Kintner RL, Jaehnig E, Van Gompel JJ. Multiple determinants contribute
to the virulence of HSV ocular and CNS infection and identification of serine
34 of the US1 gene as an ocular disease determinant. Invest Ophthalmol Vis
Sci 44:2657-2668, 2003.
10. de la
Fuente C, Maddukuri A, Kehn K, Baylor SY, Deng L, Pumfery A, and
Kashanchi F. Pharmacological cyclin-dependent kinase inhibitors as HIV-1
antiviral therapeutics. Curr HIV Res 1:131-152, 2003.
11. Pumfery A, Deng L,
Maddukuri A, de la Fuente C, Li H, Wade JD, Lambert P, Kumar A, and Kashanchi
F. Chromatin remodeling and
modification during HIV-1 Tat-activated transcription. Curr HIV Res
1:261-274, 2003.
12. Zhou M, Deng L, Lacoste V,
Park HU, Pumfery A, Kashanchi F,
Brady JN, Kumar A. Coordination of transcription factor phosphorylation and
histone methylation by the P-TEFb kinase
during human immunodeficiency virus type 1 transcription. J Virol 78:13522-13533, 2004.
13. Ghedin E, Pumfery A,
de la Fuente C, Yao K, Miller N, Lacoste V, Fraser C, Quackenbush J, Jacobson S, and Kashanchi F. Use
of a multi‑virus array for the study of human viral and retroviral pathogens:
gene expression studies and ChIP‑chip analysis. Retrovirol 1:10,
2004.
14. Lacoste V, de la Fuente C,
Kashanchi F, and Pumfery A.
Kaposi’s sarcoma-associated herpesvirus immediate early gene activity. Front
Biosci 9:2245-2272, 2004.
15. Kehn K, Berro R, de la Fuente
C, Strouss K, Ghedin E, Dadgar S, Bottazzi ME, Pumfery A, and Kashanchi
F. Mechanisms of HTLV-1 transformation. Front Biosci 9:2347-2372, 2004.
16. Seelamgari A, Maddukuri A,
Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, and Kashanchi
F. Role of viral regulatory and accessory proteins in HIV-1 replication.
Front Biosci 9:2388-2413, 2004.
17. Kehn K, Deng L, de la Fuente
C, Strouss K, Wu K, Maddukuri A, Baylor S, Rufner R, Pumfery A, Bottazzi
ME, and Kashanchi F. The role of cyclin D2 and p21/waf1 in human T-cell
leukemia virus type 1 infected cells. Retrovirol 1:6, 2004.
18. Wu K, Bottazzi ME, de la
Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery
A, and Kashanchi F. Protein profile of Tax-associated complexes. J Biol
Chem 279:495-508, 2004.
19. Agbottah E, de La Fuente C,
Nekhai S, Barnett A, Gianella-Borradori
A, Pumfery A, Kashanchi F. Antiviral
activity of Cyc202 in HIV-1 infected cells. J
Biol Chem 280:3029-4204, 2005.
20. Kehn K, de la Fuente C,
Strouss K, Berro R, Jiang H, Brady J, Mahieux R, Pumfery A, Bottazzi
ME, Kashanchi F. The HTLV-I Tax oncoprotein targets the Retinoblastoma (Rb) protein for
proteasomal degradation. Oncogene 24:525-540, 2005.
21. Liang
WS, Maddukuri A, Teslovich T, de la Fuente C, Seelamgari A, Kehn K, Baylor S,
Hautaniemi S, Pumfery A, Stephan DA,
and Kashanchi F. Therapeutic Targets For HIV-1 Infection In The Host
Proteome. Retrovirology 2:20, 2005.
22. Pumfery A, de la Fuente C, Berro R, Nekhai S, Kashanchi
F, and Chao SH. Potential use
of pharmacological cyclin‑dependent kinase inhibitors as anti‑HIV therapeutics.
Curr Pharm Design, 12:1949-1961. 2006.
23. Agbottah
E, Zhang N, Dadgar S, Pumfery A,
Wade JD, Zeng C, and Kashanchi F. Inhibition of HIV-1 virus replication using
small soluble Tat peptides. Virology 345:373.
2006.
24. Berro R, Kehn K, de la Fuente
C, Pumfery A, Adair R, Wade J,
Colberg-Poely A, Hiscott J, and Kashanchi F. Acetylated
Tat regulates HIV-1 splicing through its interaction with the splicing regulator,
p32. J Virol 80:3189. 2006.
25. de la Fuente C, Gupta MV,
Klase Z, Strouss K, CahanP, McCaffery T, Galante A, Soteropoulous P, Pumfery A, Fujii M, and Kashanchi F.
Involvement of HTLV-1 Tax and CREB in aneuploidy: A bioinformatics approach. Retrovirology. 3:43, 2006.
26. Pumfery A, de la Fuente C, and Kashanchi F. HTLV-1 Tax: Centrosome
amplification and cancer. Retrovirology,
3:50, 2006.
27. Agbottah E, Deng L, Pumfery A, and Kashanchi F. Effect of a
chromatin remodeling complex on HIV-1 activated transcription. Retrovirology. 3:48, 2006.
28. Berro R, de la Fuente C,
Klase Z, Kehn K, Parvin L, Pumfery
A, Agbottah E, Vertes A, Nekhai S, and Kashanchi F. Identifying the
membrane proteome of HIV-1 infected cells. J
Biol Chem. 282:8207-18, 2007.
`29. Mody M, Dharker N, Bloomston M,
Glickman T, McCaffrey T, Yang Z, Pumfery
A, Lee D, Ringel MD, and Pinzone JJ. Rosiglitazone
Sensitises MDA-MB-231 Breast Cancer Cells to Anti-tumour Effects of TNF, CH11
and CYC202. Endocr Relat Cancer.
4(2):305-15,
2007
Book Chapters
1. Brandt CR, Kintner RL, Visalli
RJ, and Pumfery AM. Ribonucleotide
reductase and the ocular virulence of HSV-1, pp136-150. in Pathogenicity of
human herpes viruses and specific pathogenicity genes, Frontiers in Virology
vol. 3. G Daria and Y Becher, eds. 1994, Springer-Verlag, Berlin.
2. Pumfery A, Berro R, and Kashanchi F. Proteomics of Viruses. In Medical Applications of Mass Spectrometry.
K Vekey, A Telekes, A Vertes, Eds. 2008. Elsevier Publishers
Invited Presentations
1. Pumfery A. “DNA Fingerprinting
Workshop”. Essex County Essex County College Division of Biology and Chemistry,
Newark NJ. November 16, 2017
2. Pumfery A. “DNA Fingerprinting and the Law”, panel discussion. Essex County
Essex County College Division of Biology and Chemistry, Newark NJ. April 2,
2015.
3. Pumfery A. “The Virology of Ebola”. Essex County College Division of Biology
and Chemistry, Newark NJ. December 11, 2014.
4. Pumfery A. “Ebola Virus Panel Discussion”. Essex County College, Newark NJ.
November 13, 2014.
5. Pumfery A. “Influenza, Colds, and Vaccines”. Essex County College Division
of Biology and Chemistry, Newark NJ. February 28, 2013.
6. Pumfery A. “The Human Herpesviruses”. Essex County College Division of
Biology and Chemistry, Newark NJ. November 3, 2011.
7. Pumfery A. “Issues of Gender Equity” 90th National meeting /Graduate
Women in Science. Cornell University, Ithaca NY. June 18, 2011.
8. Pumfery A. “The HPV Vaccine and Prevention of Cervical Cancer”. Graduate
Women in Science Kappa chapter. March 19, 2007.
9. Pumfery AM. “Kinases as Antivirals”. Seton Hall University Department of
Chemistry and Biochemistry. April 4, 2006.
Conferences
1. The 12th Annual Workshop on
Kaposi's Sarcoma-Associated Herpesvirus (KSHV) and Related Agents, Charleston,
South Carolina (September 13-16, 2009). “Characterization of KSHV ORF11 as
a possible inhibitor of ORF50/Rta” C.
N. Ramirez, S.A. Creighton, J. Guito, D.M. Lukac, and A. M. Pumfery
2. 33rd Annual
International Herpesvirus Workshop, Estoril, Portugal (July 27 - August 1, 2008). “Characterization
of Kaposi’s sarcoma-associated herpesvirus ORF11” A.M. Pumfery and C.N. Ramirez
3. 10th International
Conference on Malignancies in AIDS, Bethesda MD (October 16-17, 2006).
“Involvement of Cyclin Dependent Kinases in KSHV Gene Expression”. V. Lacoste,
C. de la Fuente, R. Berro, S. Jacobson, E. Ghedin, F. Kashanchi, A. Pumfery
4. 25th International
Herpesvirus Workshop. Boston, MA (1999). “The human herpesvirus 6 Ts protein
inhibits HIV-1 replication and the minimal domain for suppression of the HIV-1
LTR lies between amino acids 147 and 225”. A.M.
Pumfery, F.Kashanchi, and L.J.Rosenthal
5. International Conference on
Herpetic Eye Diseases. New Orleans, LA. (1992). “Biological and histological
characterization of HSV-1 recombinants with increased ocular and
neurovirulence”. Pumfery AM, Brandt CR, and Dubielzig RR.
